Family · Pharmaceutical analytical standards
Suxamethonium
A depolarising muscle relaxant with a very fast, short action, used in anaesthesia to ease tracheal intubation, including in emergencies; it entered clinical practice in 1951 and has been included in the WHO Model List of Essential Medicines. This family brings together the active ingredient, nitrosamines and other impurities.
Did you know?It was described as early as 1906 by Reid Hunt and René de M. Taveau, who missed its paralysing effect because their animals had been given curare.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
